Wei Wu He logo

Wei Wu He

Description

Dr. He has been serving as Executive Chairman of Human Longevity Inc since July 2019. Prior to HLI, Dr. He was the CEO of OriGene Technologi...

Investor Profile

Wei Wu He has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Medical, Pharmaceutical.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Wei Wu He frequently co-invest with?

Venrock Healthcare Capital Partners
North America, California, United States, Palo Alto
Co-Investments: 1
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 1
Panacea Venture
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1

What are some of recent deals done by Wei Wu He?

CASI Pharmaceuticals

Rockville, Maryland, United States

CASI focus on building a pipeline through mutually beneficial business development transactions.

BiotechnologyMedicalPharmaceutical
Post Ipo EquityJun 26, 2024
Amount Raised: $15,000,000